Journal of Cancer Immunology

Specific aims of the issue:

To publish original research, review articles, and commentaries.

Submission Guidelines

Authors are advised to submit manuscripts directly to following editorial manager desk- https://www.scientificarchives.com/submit or the author may directly send the manuscript along with all the necessary supplement documents to the following email address: cancerimmunol@scientific-archives.net

During submission, the author must assure that –

Submissions must neither have been submitted nor published elsewhere.
All the manuscripts submitted to this special issue will be peer-reviewed by two independent reviewers and selected in accordance with the journal standards.
If choosing to contribute a review, please submit a brief (1-2 sentence description) for pre-review by the guest editors.

A Special Issue on "Cancer Immunotherapy and Immune Checkpoint Inhibitors" in the Journal of Cancer Immunology would highlight one of the most transformative areas in modern oncology. Cancer immunotherapy has revolutionized cancer treatment by harnessing the immune system to recognize and eliminate tumor cells, while immune checkpoint inhibitors have demonstrated remarkable clinical success across a wide range of malignancies.

The interdisciplinary nature of this field encourages contributions from researchers in immunology, oncology, molecular biology, translational medicine, bioinformatics, and clinical sciences, fostering meaningful scientific discussion and collaboration. This Special Issue would provide a platform to showcase recent advances in immune checkpoint blockade, novel immunotherapeutic strategies, combination therapies, predictive biomarkers, mechanisms of treatment resistance, tumor microenvironment interactions, and emerging next-generation immune targets.